A systematic review and meta-analysis of randomized controlled trials found that peptide-based therapies were associated with modest improvements in several signs of skin aging, particularly hydration, brightness, and wrinkle appearance, with stronger evidence supporting oral formulations than topical therapies.
The analysis, published in Frontiers in Medicine, evaluated 19 randomized controlled trials including 1,341 patients with clinical signs of skin aging, such as wrinkles, dryness, and reduced elasticity. Researchers assessed both oral and topical peptide formulations across outcomes including hydration, elasticity, wrinkle reduction, and skin brightness.
Overall, peptide therapies were associated with statistically significant improvements in skin hydration and wrinkle appearance compared with placebo. Hydration showed one of the most consistent benefits, and skin brightness also improved significantly. Findings for skin roughness were borderline and should be interpreted cautiously.
In contrast, pooled analyses did not demonstrate statistically significant improvements in skin elasticity or density, although some individual studies reported favorable effects. These findings suggest that while peptides may improve certain cosmetic skin parameters, their effects are not consistent across all markers of aging.
Evidence Stronger for Oral Formulations
Subgroup analyses indicated that oral peptide formulations contributed to much of the observed benefit, particularly for hydration and wrinkle reduction. However, direct comparisons between oral and topical therapies were limited.
Most included studies evaluated oral peptides, accounting for more than 90% of participants, while only two trials assessed topical treatments. This imbalance restricts the ability to directly compare their relative effectiveness and suggests a stronger evidence base for oral supplementation.
The researchers noted that oral peptides may exert systemic effects after absorption, potentially influencing collagen production and extracellular matrix activity. In contrast, topical peptides may face challenges penetrating the skin barrier.
Mechanisms and Clinical Implications
Peptides may support skin structure and repair through multiple mechanisms, including stimulating fibroblast activity, promoting collagen and elastin synthesis, and supporting extracellular matrix integrity. Some peptides may also inhibit enzymes that degrade structural proteins or modulate neuromuscular activity involved in wrinkle formation.
The findings suggest that peptide-based therapies may serve as a noninvasive adjunct in aesthetic dermatology. However, the overall magnitude of benefit was modest and should be interpreted cautiously given variability across studies.
Safety Profile and Study Limitations
Peptide therapies were generally well tolerated across trials, with minimal adverse events reported. Mild gastrointestinal discomfort was occasionally noted with oral formulations, and the review reported overall patient satisfaction of 80%, although assessment methods varied across studies. No serious safety concerns were identified.
The analysis also highlighted several limitations, including substantial heterogeneity in peptide types, dosing, treatment duration, and outcome measurement methods. Many trials lacked standardized assessment techniques, making comparisons difficult. The limited number of topical studies further constrained conclusions regarding differences between delivery methods.
Need for Standardized Research
The authors concluded that while peptides appear safe and are associated with measurable improvements in some skin-aging parameters, larger and more standardized randomized controlled trials are needed to confirm these findings. Future studies should incorporate consistent outcome measures, better reporting of peptide formulations, and more balanced comparisons between oral and topical approaches.
Until then, peptide-based therapies may be considered a complementary option for improving hydration and overall skin appearance, with the strongest evidence currently supporting oral formulations.
The study authors reported no conflicts of interest.
Source: Frontiers in Medicine
